151 related articles for article (PubMed ID: 12731609)
1. The use of enamel matrix protein in the treatment of localized aggressive periodontitis: a case report.
Bonta H; Llambes F; Moretti AJ; Mathur H; Bouwsma OJ
Quintessence Int; 2003 Apr; 34(4):247-52. PubMed ID: 12731609
[TBL] [Abstract][Full Text] [Related]
2. Minimally invasive flap surgery and enamel matrix derivative in the treatment of localized aggressive periodontitis: case report.
Kaner D; Bernimoulin JP; Kleber BM; Friedmann A
Int J Periodontics Restorative Dent; 2009 Feb; 29(1):89-97. PubMed ID: 19244886
[TBL] [Abstract][Full Text] [Related]
3. Periodontal regeneration with enamel matrix derivative--case reports.
Manor A
J Int Acad Periodontol; 2000 Apr; 2(2):44-8. PubMed ID: 12666960
[TBL] [Abstract][Full Text] [Related]
4. Successful management of aggressive periodontitis by regenerative therapy: a 3-year follow-up case report.
Miliauskaite A; Selimovic D; Hannig M
J Periodontol; 2007 Oct; 78(10):2043-50. PubMed ID: 18062127
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study.
Francetti L; Trombelli L; Lombardo G; Guida L; Cafiero C; Roccuzzo M; Carusi G; Del Fabbro M
Int J Periodontics Restorative Dent; 2005 Oct; 25(5):461-73. PubMed ID: 16250568
[TBL] [Abstract][Full Text] [Related]
6. Two patterns of histologic healing in an intrabony defect following treatment with enamel matrix derivative: a human case report.
Majzoub Z; Bobbo M; Atiyeh F; Cordioli G
Int J Periodontics Restorative Dent; 2005 Jun; 25(3):283-94. PubMed ID: 16001741
[TBL] [Abstract][Full Text] [Related]
7. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
[TBL] [Abstract][Full Text] [Related]
8. The combined use of enamel matrix proteins and a tetracycline-coated expanded polytetrafluoroethylene barrier membrane in the treatment of intra-osseous defects.
Sipos PM; Loos BG; Abbas F; Timmerman MF; van der Velden U
J Clin Periodontol; 2005 Jul; 32(7):765-72. PubMed ID: 15966884
[TBL] [Abstract][Full Text] [Related]
9. Nine-year results following treatment of intrabony periodontal defects with an enamel matrix derivative: report of 26 cases.
Sculean A; Schwarz F; Chiantella GC; Arweiler NB; Becker J
Int J Periodontics Restorative Dent; 2007 Jun; 27(3):221-9. PubMed ID: 17694945
[TBL] [Abstract][Full Text] [Related]
10. Human histologic evaluation of an intrabony defect treated with enamel matrix derivative, xenograft, and GTR.
Sculean A; Windisch P; Chiantella GC
Int J Periodontics Restorative Dent; 2004 Aug; 24(4):326-33. PubMed ID: 15446402
[TBL] [Abstract][Full Text] [Related]
11. Localized aggressive periodontitis in a six-year-old: a case report.
Hilgers KK; Dean JW; Mathieu GP
Pediatr Dent; 2004; 26(4):345-51. PubMed ID: 15344629
[TBL] [Abstract][Full Text] [Related]
12. Reconstruction of supracrestal alveolar bone lost as a result of severe chronic periodontitis. Five-year outcome: case report.
Kotschy P; Laky M
Int J Periodontics Restorative Dent; 2006 Oct; 26(5):425-31. PubMed ID: 17073352
[TBL] [Abstract][Full Text] [Related]
13. Clinical and microbiological changes in a child with rapid alveolar bone loss and refill.
Ooshima T; Takiguchi M; Tamura K; Nishiyama N
ASDC J Dent Child; 2002; 69(2):143-7, 123. PubMed ID: 12515055
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of localized intrabony periodontal defects with enamel matrix derivative (Emdogain). Case series].
Szatmári P; Gera I
Fogorv Sz; 2014 Mar; 107(1):15-28. PubMed ID: 24812749
[TBL] [Abstract][Full Text] [Related]
15. Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects.
Tonetti MS; Fourmousis I; Suvan J; Cortellini P; Brägger U; Lang NP;
J Clin Periodontol; 2004 Dec; 31(12):1092-8. PubMed ID: 15560811
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical observation of treatment of infrabony defects with enamel matrix derivative (Emdogain): surgical reentry.
Rasperini G; Silvestri M; Ricci G
Int J Periodontics Restorative Dent; 2005 Apr; 25(2):121-7. PubMed ID: 15839588
[TBL] [Abstract][Full Text] [Related]
17. The application of an enamel matrix protein derivative (Emdogain) in regenerative periodontal therapy: a review.
Sculean A; Schwarz F; Becker J; Brecx M
Med Princ Pract; 2007; 16(3):167-80. PubMed ID: 17409750
[TBL] [Abstract][Full Text] [Related]
18. Platelet gel biotechnology applied to regenerative surgery of intrabony defects in patients with refractory generalized aggressive peridontitis. Case report.
Mauro S; Orlando L; Panzoni R; Orlando PF
Minerva Stomatol; 2003; 52(7-8):401-12. PubMed ID: 14608261
[TBL] [Abstract][Full Text] [Related]
19. Clinical success in regeneration: report of a case.
Dodson SA; Takei HH; Carranza FA
Int J Periodontics Restorative Dent; 1996 Oct; 16(5):455-61. PubMed ID: 9084318
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized-controlled clinical trial.
Jepsen S; Topoll H; Rengers H; Heinz B; Teich M; Hoffmann T; Al-Machot E; Meyle J; Jervøe-Storm PM
J Clin Periodontol; 2008 May; 35(5):420-8. PubMed ID: 18341601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
